Skip to content

What conditions have Regenerative Medicine been applied and studied?

  • Achilles Tendinosis
  • ALS
  • Alzheimer’s Disease
  • Anti-Aging
  • Cancer
  • Corneal Disease, Cataracts, Glaucoma
  • Disc Degeneration in Spine
  • Hair Restoration
  • Heart Disease
  • Leukemia
  • Liver Disease
  • Lymphoma
  • Meniscus Tear
  • Osteoarthritis
  • Plantar Fasciitis
  • Parkinson’s Disease
  • Rotator Cuff Injuries
  • Sexual Health
  • Skin Rejuvenation
  • Spinal Cord Injuries
  • Stroke
  • Tendinitis
  • Type 1 Diabetes
  • Wounds (Injury, Burns, PAD, DVT)

History of Regenerative Medicine

Regenerative medicine is focused on developing and applying new treatments to heal tissues and organs, and restore function lost due to aging, disease, damage, or defects.

  • Early 1800’s: Scientists revealed all life depends on chemical reactions within cell and could be reproduced in the lab.
  • Early 1900’s: Scientists discover DNA and its impact on cell division.
  • Mid 1900’s: Organ transplantation, surgical implants and bio-materials led to the ability to grow and harvest tissues for transplantation.
  • 2000’s: PRP (Platelet Rick Plasma) and Extracellular Vesicles (Exosomes) emerge with over 20 years of research and 150+ clinical studies.

This advancement in knowledge created the field of Regenerative Medicine as we know it today.

What types of Regenerative Aesthetic Medicine Therapies are available?

Regenerative medicine biologics are classified in two categories: Autologous (derived from the patient) or Allogeneic (derived from a donor.) PRP/PRF is autologous, where AFA and EV’s are allogeneic.

  • PRP/PRF (Platelet Rich Plasma/Fibrin): The drawing and processing of a patient’s blood that isolates the platelets know to contain growth factors that stimulate tissue regeneration.
  • AFA (Amniotic Fluid Allograft): Ethically collected, CLIA lab tested and sterilized AFA is known to contain cytokines and growth factors that aren’t diminished by patient age or lifestyle.
  • EV’s (Extracellular Vesicles): This therapy includes exosomes (MiRNA), growth factors and cytokines that are ethically collected, CLIA lab tested and sterilized and in clinical studies have outperformed PRP due to not being limited by the health and age of the donor patient.
Back To Top